2-Bromo-6-fluorotoluene | CAS:1422-54-4

We serve 2-Bromo-6-fluorotoluene CAS:1422-54-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Bromo-6-fluorotoluene

Product Name: 2-Bromo-6-fluorotoluene
Other Name: 6-Bromo-2-fluorotoluene;2-Fluoro-6-Bromo Toluene;1-Bromo-3-fluoro-2-methylbenzene
CAS No: 1422-54-4
MF: C7H6BrF
MW: 189.02500
Density: 1.53
Boiling point: 75-76°C 10mm
Flash point: 76°C
Refractive index: 1.535
Vapor Pressure: 0.00166mmHg at 25°C
UN Number: UN2811
UN Proper Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Transport hazard class: 6.1
Packing group: II
 
Specification
Appearance: Colorless to yellow liquid
Purity: ≥98%
Water: ≤0.5%
 
Application: Organic intermediates, pharmaceutical intermediates.
Package: 25kg/drum, packed in plastic drum or plastic coated iron drum.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 2-Bromo-6-fluorotoluene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Bromo-3-fluoro-2-methylbenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Bromo-3-fluoro-2-methylbenzene Use and application,6-Bromo-2-fluorotoluene technical grade,usp/ep/jp grade.


Related News: The Transport Security Administration (TSA) will issue a new security directive to airlines from Sunday, according to a person briefed on the restrictions.Acetoacet-p-phenetidide manufacturer This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.2-oxo-6-(trifluoromethyl)-1H-pyridine-3-carboxylic acid supplier This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.2,6-dichlorobenzenethiol vendor International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.